GGrantIndex
Sort

53,477 grants matching addiction

QuitSpit: An Internet-Based Smokeless Tobacco Cessation Program for Teens

$520,938
Herbert H Severson · Oregon Research Institute · R01 · FY2006 · CA

Epigenetic Heterogeneity as a Driver of Liver Disease and Cancer

$520,900
Keith D Robertson · Mayo Clinic Rochester · R01 · FY2018 · AA

A Molecular Analysis of the Gateway Hypothesis in Mice

$520,878
Eric R Kandel · Columbia University Health Sciences · R01 · FY2009 · DA

Gender-Responsive Treatment for Women Offenders

$520,847
University Of California Los Angeles · R01 · FY2004 · DA

Implementing Opioid Risk Reduction Strategies into Primary Care Practice

$520,795
Karen Elizabeth Lasser · Boston Medical Center · R01 · FY2013 · DA

Psychology of Alcohol and Addiction Training

$520,776
Denis M McCarthy · University Of Missouri-Columbia · T32 · FY2022 · AA

Studies with Nicotinic Null Mutant Mice

$520,740
Michael J Marks · University Of Colorado · P30 · FY2010 · DA

Mechanisms Linking Social and Built Environments to Health in the 30s

$520,720
Richard Kosterman · University Of Washington · R01 · FY2016 · DA

Behavioral and epigenetic mechanisms in extinction of cocaine-induced memories

$520,709
Kennon Matthew Lattal · Oregon Health & Science University · R01 · FY2018 · DA

Behavioral and epigenetic mechanisms in extinction of cocaine-induced memories

$520,709
Kennon Matthew Lattal · Oregon Health & Science University · R01 · FY2017 · DA

Intensive Motivational Interviewing for Methamphetamine Dependence

$520,701
Douglas L Polcin · Public Health Institute · R01 · FY2009 · DA

Immunotherapy to Counteract Lethal Doses of Carfentanil

$520,662
Kim D Janda · Scripps Research Institute, The · U01 · FY2019 · DA

Hypothalamic-Pituitary-Adrenal Axis and Alcoholism

$520,635
Gary S Wand · Johns Hopkins University · R01 · FY2008 · AA

ROLE OF OREXIN IN COCAINE DEMAND AND ADDICTION

$520,634
Gary S. Aston-Jones · Rbhs-Robert Wood Johnson Medical School · R01 · FY2021 · DA

Diet, Insulin, Dopamine, and Reward.

$520,604
Margaret E Rice · New York University School Of Medicine · R01 · FY2016 · DA

Molecular Neurobiology of Human Drug Abuse

$520,448
Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · DA

Enhanced MI with Alcohol Positive Trauma Patients

$520,349
Peter M. Monti · Brown University · R01 · FY2009 · AA

Genomic and functional approaches to characterize Chr1q gains in cancer

$520,332
Jason Sheltzer · Yale University · R01 · FY2025 · CA

Imaging and Neural Circuits Core

$520,283
Charles Chavkin · University Of Washington · P30 · FY2023 · DA

Uncovering the roles of oxysterols in neuropathic pain

$520,274
Daniela Salvemini · Saint Louis University · R01 · FY2022 · NS

Studies with Nicotinic Null Mutant Mice

$520,271
Michael J Marks · University Of Colorado · P30 · FY2011 · DA

A Clinical Laboratory with Integrated Neuroscience (CLIN) for Early Evaluation of Medications for Substance Use Disorders

$520,270
Kyle Matthew Kampman · University Of Pennsylvania · UG1 · FY2021 · DA

Quetiapine for the treatment of Type A and Type B alcoholism

$520,268
Kyle Matthew Kampman · University Of Pennsylvania · R01 · FY2008 · AA

Vulnerability to Drug Abuse:Pathways to Recovery

$520,235
Elizabeth J Costello · Duke University · R01 · FY2012 · DA

Endocannabinoid brain mechanisms and addiction

$520,196
Eliot Gardner · National Institute On Drug Abuse · ZIA · FY2011 · DA